Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02340780
Title Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Indications

chronic lymphocytic leukemia

Therapies

Buparlisib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.